Jiaping Peng

Title: Jiaping Peng: Innovator in Antibody Therapeutics

Introduction

Jiaping Peng is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of antibody therapeutics, holding 2 patents that focus on innovative treatments involving antibodies against ENPP3. His work is pivotal in advancing medical science and therapeutic methods.

Latest Patents

Jiaping Peng's latest patents include groundbreaking research on the therapeutic use of antibodies against ENPP3. The first patent discloses monoclonal antibodies against ENPP3, bispecific antibodies against ENPP3 and CD3, as well as nucleic acids that encode these antibodies. It also covers vectors and host cells that incorporate these nucleic acids, along with pharmaceutical compositions and conjugates that utilize the antibodies. The second patent reiterates these findings, emphasizing the potential therapeutic methods for using these antibodies in clinical applications.

Career Highlights

Jiaping Peng is currently associated with Zhejiang Shimai Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His expertise in antibody development has positioned him as a key figure in the industry, contributing to advancements that may lead to new treatment options for various diseases.

Collaborations

Jiaping has collaborated with notable colleagues such as Zuoxiang Xiao and Dongwen Zhou. Their combined efforts in research and development have further enhanced the impact of their work in the pharmaceutical sector.

Conclusion

Jiaping Peng's contributions to antibody therapeutics exemplify the importance of innovation in medicine. His patents and ongoing work at Zhejiang Shimai Pharmaceutical Co., Ltd. highlight his commitment to advancing healthcare solutions.